News | April 28, 2022
Sanofi continues to deliver strong business
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Glenmark Pharmaceuticals won Innovation of the Year award
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors
Results support the development of tislelizumab in potentially synergistic combinations across Novartis advanced therapeutic platforms for the treatment of an array of solid tumours
Subscribe To Our Newsletter & Stay Updated
